Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors

Journal of Neurosurgery

Volumn 86, Issue 1, 1997, Pages 22-27

  Siegal, Tali ^a   Rubinstein, Rina ^a   Tzuk Shina, Tzahala ^a   Gomori, John M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

brain neoplasm; brain perfusion; cerebral blood vessel; gadolinium; magnetic resonance imaging; thallium 201

Indexed keywords

GADOLINIUM; THALLIUM 201;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN MAPPING; BRAIN PERFUSION; BRAIN TUMOR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR GROWTH;

EID: 0031032721     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.1.0022     Document Type: Article

References (15)

1. Aronen HJ, Gazit IE, Louis DN, et al: Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51, 1994
2. Belliveau JW, Rosen BR, Kantor HL, et al: Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14:538-546, 1990
3. Black KL, Emeriek T, Hoh C, et al: Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 16:93-96, 1994
4. Edelman RR, Mattle HP, Atkinson DJ, et al: Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 176:211-220, 1990
5. Gomori JM, Tzuk-Shina T, Rubinstein R, et al: MR cerebral blood volume maps of brain tumors: comparison with thallium SPECT, tumor grade and clinical data. Int J Neuroradiol 1: 127-133, 1995
6. Guckel F, Brix G, Deimling M, et al: Assessment of cerebral blood flow dynamic with contrast-enhanced T2*-weighted gradient echo images, in: Society of Magnetic Resonance in Medicine (eds): Book of Abstracts. Eleventh Annual Scientific Meeting. August 8-14, 1992. Berlin, Germany. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1997, Vol 1, p 1113 (Abstract)
7. 18F-fluorodeoxyglucose PET. AJR 163:1459-1465, 1994
8. Kaplan WD, Takvorian T, Morris JH, et al: Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 28:47-52, 1987
9. Kim KT, Black KL, Marciano D, et al: Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 31:965-969, 1990
10. Rosen BR, Belliveau JW, Aronen HJ, et al: Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 22:293-299, 1991
11. Rosen BR, Belliveau JW, Vevea JM, et al: Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265, 1990
12. 201thallium brain SPECT, image registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 21:188-195, 1996
13. Tzika AA, Massoth RJ, Ball WS Jr, et al: Cerebral perfusion in children: detection with dynamic contrast-enhanced T2*-weighted MR images. Radiology 187:449-458, 1993
14. Vertosick FT Jr, Selker RG, Grossman SJ, et al: Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 34:396-401, 1994
15. White DL, Aicher KP, Tzika AA, et al: Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain. Magn Reson Med 24:14-28, 1992